ArticleProceedings of the National Academy of Sciences of the United States of America2025

Development of DPP-4-resistant CXCL9-Fc and CXCL10-Fc chemokines for effective cancer immunotherapy.

Jennie Lugassy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.